The VALIDATE Network - Vaccine development for complex intracellular neglected pathogens
Infections and Immunity Board (IIB) - New Investigator Research Grant, 2021
Deadline: 9 September 2021 16:00
Opens: 20 July 2021
The New Investigator Research Grant (NIRG) is aimed at researchers who are capable of becoming independent Principal Investigators and who are now ready to take the next step towards that goal. A NIRG is normally of three years duration. The scheme does not cover research involving trials of clinical treatments.
The Infections and Immunity Board (IIB) funds research into infectious human disease and disorders of the human immune system. This is underpinned by fundamental research into human pathogens, as well as the normal development and functioning of the human immune system. They fund basic, clinical and translational research into pathogens implicated in human infectious diseases. This includes an understanding of the pathogen at the molecular and cellular level through to host pathogen interactions and into epidemiology of infectious diseases. They are also keen to fund research to inform novel strategies for preventing and controlling infectious and immune disease control, including research on human behaviour and lifestyle.
Who can apply?
To be considered suitable for the scheme, applicants should be able to clearly demonstrate that their skills and experience at the time of their application match those of the transition to independence career stage, as set out in the Applicant skills and experience table.
There are no eligibility rules based on years of post-doctoral experience. The minimum formal qualification required is a graduate degree. Most applicants are also expected to have a PhD or an MD.
For the full call text please visit the MRC grant call webpage.